Dr. Nicolle Gatto, PhD, MPH—SVP, Scientific Research, Aetion
Dr. Gatto is an epidemiologist with 20 years of industry experience. As Aetion’s Scientific Research Head, Dr. Gatto serves as a scientific voice within the company ensuring appropriate and principled use of real-world data/evidence, designing and communicating scientific frameworks, standards and methodologies, and collaborating with stakeholders globally.Read more
In her role at Aetion, she has collaborated with FDA as part of Aetion’s Research Collaborative Agreement with the Agency, actively participated in the Reagan-Udall Foundation’s Evidence Accelerator program, and leads the scientific team supporting these efforts.
Prior to Aetion, Dr. Gatto was the Group Head for Vaccines and Oncology with the Epidemiology Group at Pfizer, providing strategic leadership, oversight of comprehensive epidemiology strategies to examine the safety of medicines, consultation on design of pragmatic trials and hybrid studies, and expertise on methods-related epidemiologic issues. She has designed and implemented primary and secondary data collection observational studies and pragmatic trials, and has presented to and negotiated these studies with FDA and EMA. Dr. Gatto is Fellow of the International Society for Pharmacoepidemiology and an Adjunct Assistant Professor of Epidemiology at Columbia University and Tulane, teaching courses in pharmacoepidemiology, causal inference and confounding control methods.
